[Benefits and risks of immunostimulation with interleukin 12].
Ryffel
B
B
Institut für Pathologie, Universität Basel.
D015551:Autoimmunity / Q000187:drug effects; D003141:Communicable Diseases / Q000276:immunology / Q000628:therapy; D006801:Humans; D007114:Immunization / Q000009:adverse effects / Q000379:methods*; D018664:Interleukin-12 / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy
D018664:Interleukin-12
Nutzen und Risiko der Immunstimulation mit Interleukin 12.